Search

Author/Creator Mahajan, Anadi

3. Efficacy of emicizumab prophylaxis versus factor VIII prophylaxis for treatment of hemophilia A without inhibitors: network meta-analysis and sub-group analyses of the intra-patient comparison of the HAVEN 3 trial. (2nd December 2019)

Authors:
Reyes, Adriana; Révil, Cédric; Niggli, Markus; Chebon, Sammy; Schlagmüller, Simone; Flacke, Jan-Paul; Zortel, Max; Paz-Priel, Ido; Asikanius, Elina; Hampton, Roger; Mahajan, Anadi; Schmidt, Elvira; Edwards, Susan C.
Journal:
Current medical research and opinion
Issue:
Volume 35:Number 12(2019)
Page Start:
2079
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Reply: RE: Reyes A, Révil C, Niggli M, et al. Efficacy of emicizumab prophylaxis versus factor VIII prophylaxis for treatment of hemophilia A without inhibitors: network meta-analysis and sub-group analyses of the intra-patient comparison of the HAVEN 3 trial. Curr Med Res Opin. 2019;35(12):2079–2087. (2nd July 2020)

Authors:
Reyes, Adriana; Révil, Cédric; Niggli, Markus; Chebon, Sammy; Schlagmüller, Simone; Flacke, Jan-Paul; Zortel, Max; Paz-Priel, Ido; Asikanius, Elina; Hampton, Roger; Mahajan, Anadi; Schmidt, Elvira; Edwards, Susan C.
Journal:
Current medical research and opinion
Issue:
Volume 36:Number 7(2020)
Page Start:
1129
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗